nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—esophageal cancer	0.325	1	CbGaD
Quetiapine—HTR3A—vagus nerve—esophageal cancer	0.0158	0.156	CbGeAlD
Quetiapine—HTR7—vagus nerve—esophageal cancer	0.0102	0.101	CbGeAlD
Quetiapine—HTR2A—vagus nerve—esophageal cancer	0.00639	0.063	CbGeAlD
Quetiapine—CHRM3—exocrine gland—esophageal cancer	0.00369	0.0364	CbGeAlD
Quetiapine—H1F0—neck—esophageal cancer	0.00364	0.0359	CbGeAlD
Quetiapine—CHRM5—epithelium—esophageal cancer	0.00287	0.0283	CbGeAlD
Quetiapine—ADRA1D—epithelium—esophageal cancer	0.00257	0.0253	CbGeAlD
Quetiapine—H1F0—bronchus—esophageal cancer	0.00244	0.0241	CbGeAlD
Quetiapine—H1F0—smooth muscle tissue—esophageal cancer	0.00239	0.0236	CbGeAlD
Quetiapine—HTR7—neck—esophageal cancer	0.00225	0.0222	CbGeAlD
Quetiapine—H1F0—trachea—esophageal cancer	0.00219	0.0216	CbGeAlD
Quetiapine—H1F0—digestive system—esophageal cancer	0.00188	0.0186	CbGeAlD
Quetiapine—HTR3A—digestive system—esophageal cancer	0.0018	0.0177	CbGeAlD
Quetiapine—CHRM1—trachea—esophageal cancer	0.00159	0.0157	CbGeAlD
Quetiapine—H1F0—lung—esophageal cancer	0.00157	0.0155	CbGeAlD
Quetiapine—CHRM3—smooth muscle tissue—esophageal cancer	0.00155	0.0153	CbGeAlD
Quetiapine—HTR7—epithelium—esophageal cancer	0.00153	0.0151	CbGeAlD
Quetiapine—HTR3A—lung—esophageal cancer	0.0015	0.0148	CbGeAlD
Quetiapine—ADRA1A—epithelium—esophageal cancer	0.00147	0.0145	CbGeAlD
Quetiapine—HTR7—smooth muscle tissue—esophageal cancer	0.00147	0.0145	CbGeAlD
Quetiapine—HTR2A—neck—esophageal cancer	0.0014	0.0138	CbGeAlD
Quetiapine—ADRA2C—bronchus—esophageal cancer	0.00138	0.0137	CbGeAlD
Quetiapine—HTR7—trachea—esophageal cancer	0.00135	0.0133	CbGeAlD
Quetiapine—ADRA2C—trachea—esophageal cancer	0.00124	0.0123	CbGeAlD
Quetiapine—CHRM3—digestive system—esophageal cancer	0.00122	0.0121	CbGeAlD
Quetiapine—HTR7—digestive system—esophageal cancer	0.00116	0.0115	CbGeAlD
Quetiapine—HRH1—epithelium—esophageal cancer	0.00114	0.0113	CbGeAlD
Quetiapine—CHRM1—lung—esophageal cancer	0.00114	0.0113	CbGeAlD
Quetiapine—CYP2C19—digestive system—esophageal cancer	0.00114	0.0112	CbGeAlD
Quetiapine—ADRA2A—bronchus—esophageal cancer	0.0011	0.0109	CbGeAlD
Quetiapine—HRH1—smooth muscle tissue—esophageal cancer	0.0011	0.0109	CbGeAlD
Quetiapine—H1F0—lymph node—esophageal cancer	0.00108	0.0106	CbGeAlD
Quetiapine—HRH1—trachea—esophageal cancer	0.00101	0.00996	CbGeAlD
Quetiapine—ADRA2A—trachea—esophageal cancer	0.000992	0.00978	CbGeAlD
Quetiapine—HTR7—lung—esophageal cancer	0.000971	0.00958	CbGeAlD
Quetiapine—HTR2A—epithelium—esophageal cancer	0.000953	0.00941	CbGeAlD
Quetiapine—HTR2A—smooth muscle tissue—esophageal cancer	0.000919	0.00906	CbGeAlD
Quetiapine—DRD2—lung—esophageal cancer	0.000918	0.00906	CbGeAlD
Quetiapine—CYP3A5—digestive system—esophageal cancer	0.000895	0.00883	CbGeAlD
Quetiapine—ADRA2C—lung—esophageal cancer	0.000893	0.00881	CbGeAlD
Quetiapine—HRH1—digestive system—esophageal cancer	0.000868	0.00857	CbGeAlD
Quetiapine—HTR2A—trachea—esophageal cancer	0.000843	0.00832	CbGeAlD
Quetiapine—CYP3A5—lung—esophageal cancer	0.000747	0.00737	CbGeAlD
Quetiapine—HTR2A—digestive system—esophageal cancer	0.000725	0.00716	CbGeAlD
Quetiapine—HRH1—lung—esophageal cancer	0.000725	0.00716	CbGeAlD
Quetiapine—ADRA2A—lung—esophageal cancer	0.000712	0.00703	CbGeAlD
Quetiapine—Gastritis—Capecitabine—esophageal cancer	0.000676	0.00231	CcSEcCtD
Quetiapine—Muscular weakness—Capecitabine—esophageal cancer	0.000673	0.0023	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000673	0.0023	CcSEcCtD
Quetiapine—CYP3A4—digestive system—esophageal cancer	0.000671	0.00663	CbGeAlD
Quetiapine—Eye disorder—Cisplatin—esophageal cancer	0.00067	0.00229	CcSEcCtD
Quetiapine—Tinnitus—Cisplatin—esophageal cancer	0.000668	0.00229	CcSEcCtD
Quetiapine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000666	0.00228	CcSEcCtD
Quetiapine—Cardiac disorder—Cisplatin—esophageal cancer	0.000665	0.00228	CcSEcCtD
Quetiapine—Abdominal distension—Capecitabine—esophageal cancer	0.000664	0.00227	CcSEcCtD
Quetiapine—CYP2D6—digestive system—esophageal cancer	0.000661	0.00652	CbGeAlD
Quetiapine—Influenza—Capecitabine—esophageal cancer	0.00066	0.00226	CcSEcCtD
Quetiapine—Dysphagia—Capecitabine—esophageal cancer	0.00066	0.00226	CcSEcCtD
Quetiapine—Asthma—Capecitabine—esophageal cancer	0.00066	0.00226	CcSEcCtD
Quetiapine—Thrombophlebitis—Methotrexate—esophageal cancer	0.000657	0.00225	CcSEcCtD
Quetiapine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000653	0.00224	CcSEcCtD
Quetiapine—Polyuria—Methotrexate—esophageal cancer	0.000647	0.00222	CcSEcCtD
Quetiapine—Immune system disorder—Cisplatin—esophageal cancer	0.000647	0.00221	CcSEcCtD
Quetiapine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000646	0.00221	CcSEcCtD
Quetiapine—Angina pectoris—Capecitabine—esophageal cancer	0.000643	0.0022	CcSEcCtD
Quetiapine—Bronchitis—Capecitabine—esophageal cancer	0.000635	0.00217	CcSEcCtD
Quetiapine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000633	0.00216	CcSEcCtD
Quetiapine—ABCB1—epithelium—esophageal cancer	0.000625	0.00616	CbGeAlD
Quetiapine—Malnutrition—Cisplatin—esophageal cancer	0.000624	0.00213	CcSEcCtD
Quetiapine—Neutropenia—Capecitabine—esophageal cancer	0.000617	0.00211	CcSEcCtD
Quetiapine—Dysuria—Capecitabine—esophageal cancer	0.000617	0.00211	CcSEcCtD
Quetiapine—Renal failure acute—Methotrexate—esophageal cancer	0.000616	0.00211	CcSEcCtD
Quetiapine—Flatulence—Cisplatin—esophageal cancer	0.000615	0.0021	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000613	0.0021	CcSEcCtD
Quetiapine—ADRA2C—lymph node—esophageal cancer	0.000611	0.00602	CbGeAlD
Quetiapine—HTR2A—lung—esophageal cancer	0.000606	0.00598	CbGeAlD
Quetiapine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000602	0.00206	CcSEcCtD
Quetiapine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000602	0.00206	CcSEcCtD
Quetiapine—Weight increased—Capecitabine—esophageal cancer	0.0006	0.00206	CcSEcCtD
Quetiapine—Muscle spasms—Cisplatin—esophageal cancer	0.0006	0.00205	CcSEcCtD
Quetiapine—Weight decreased—Capecitabine—esophageal cancer	0.000597	0.00204	CcSEcCtD
Quetiapine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000595	0.00204	CcSEcCtD
Quetiapine—Pneumonia—Capecitabine—esophageal cancer	0.000592	0.00203	CcSEcCtD
Quetiapine—Infestation NOS—Capecitabine—esophageal cancer	0.000588	0.00201	CcSEcCtD
Quetiapine—Infestation—Capecitabine—esophageal cancer	0.000588	0.00201	CcSEcCtD
Quetiapine—Vision blurred—Cisplatin—esophageal cancer	0.000588	0.00201	CcSEcCtD
Quetiapine—Depression—Capecitabine—esophageal cancer	0.000587	0.00201	CcSEcCtD
Quetiapine—Tremor—Cisplatin—esophageal cancer	0.000584	0.002	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000583	0.002	CcSEcCtD
Quetiapine—Lethargy—Methotrexate—esophageal cancer	0.00058	0.00198	CcSEcCtD
Quetiapine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00058	0.00198	CcSEcCtD
Quetiapine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000579	0.00198	CcSEcCtD
Quetiapine—Anaemia—Cisplatin—esophageal cancer	0.000576	0.00197	CcSEcCtD
Quetiapine—Jaundice—Capecitabine—esophageal cancer	0.000573	0.00196	CcSEcCtD
Quetiapine—Stomatitis—Capecitabine—esophageal cancer	0.000573	0.00196	CcSEcCtD
Quetiapine—Conjunctivitis—Capecitabine—esophageal cancer	0.000572	0.00196	CcSEcCtD
Quetiapine—Urinary tract infection—Capecitabine—esophageal cancer	0.000572	0.00196	CcSEcCtD
Quetiapine—Osteoarthritis—Methotrexate—esophageal cancer	0.000568	0.00195	CcSEcCtD
Quetiapine—Malaise—Cisplatin—esophageal cancer	0.000562	0.00192	CcSEcCtD
Quetiapine—Leukopenia—Cisplatin—esophageal cancer	0.000558	0.00191	CcSEcCtD
Quetiapine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000556	0.0019	CcSEcCtD
Quetiapine—Epistaxis—Capecitabine—esophageal cancer	0.000555	0.0019	CcSEcCtD
Quetiapine—ABCB1—trachea—esophageal cancer	0.000552	0.00545	CbGeAlD
Quetiapine—Agranulocytosis—Capecitabine—esophageal cancer	0.000549	0.00188	CcSEcCtD
Quetiapine—Irritability—Methotrexate—esophageal cancer	0.000542	0.00186	CcSEcCtD
Quetiapine—Convulsion—Cisplatin—esophageal cancer	0.00054	0.00185	CcSEcCtD
Quetiapine—Mood swings—Methotrexate—esophageal cancer	0.000538	0.00184	CcSEcCtD
Quetiapine—Bradycardia—Capecitabine—esophageal cancer	0.000538	0.00184	CcSEcCtD
Quetiapine—Ataxia—Methotrexate—esophageal cancer	0.000534	0.00183	CcSEcCtD
Quetiapine—Myalgia—Cisplatin—esophageal cancer	0.000531	0.00182	CcSEcCtD
Quetiapine—Haemoglobin—Capecitabine—esophageal cancer	0.000531	0.00182	CcSEcCtD
Quetiapine—Rhinitis—Capecitabine—esophageal cancer	0.000529	0.00181	CcSEcCtD
Quetiapine—Anxiety—Cisplatin—esophageal cancer	0.000529	0.00181	CcSEcCtD
Quetiapine—Hepatitis—Capecitabine—esophageal cancer	0.000528	0.00181	CcSEcCtD
Quetiapine—Haemorrhage—Capecitabine—esophageal cancer	0.000528	0.00181	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000527	0.0018	CcSEcCtD
Quetiapine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000525	0.0018	CcSEcCtD
Quetiapine—Discomfort—Cisplatin—esophageal cancer	0.000525	0.0018	CcSEcCtD
Quetiapine—Pharyngitis—Capecitabine—esophageal cancer	0.000524	0.00179	CcSEcCtD
Quetiapine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000522	0.00179	CcSEcCtD
Quetiapine—Oedema peripheral—Capecitabine—esophageal cancer	0.00052	0.00178	CcSEcCtD
Quetiapine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000519	0.00178	CcSEcCtD
Quetiapine—Urethral disorder—Capecitabine—esophageal cancer	0.000518	0.00177	CcSEcCtD
Quetiapine—Flupentixol—ABCB1—esophageal cancer	0.000515	0.186	CrCbGaD
Quetiapine—Breast disorder—Methotrexate—esophageal cancer	0.000514	0.00176	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000512	0.00175	CcSEcCtD
Quetiapine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000509	0.00174	CcSEcCtD
Quetiapine—Visual impairment—Capecitabine—esophageal cancer	0.000509	0.00174	CcSEcCtD
Quetiapine—Infection—Cisplatin—esophageal cancer	0.000506	0.00173	CcSEcCtD
Quetiapine—Clozapine—CYP1B1—esophageal cancer	0.000501	0.181	CrCbGaD
Quetiapine—Erythema multiforme—Capecitabine—esophageal cancer	0.000499	0.00171	CcSEcCtD
Quetiapine—Nervous system disorder—Cisplatin—esophageal cancer	0.000499	0.00171	CcSEcCtD
Quetiapine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000498	0.00171	CcSEcCtD
Quetiapine—Tachycardia—Cisplatin—esophageal cancer	0.000497	0.0017	CcSEcCtD
Quetiapine—HRH1—lymph node—esophageal cancer	0.000496	0.00489	CbGeAlD
Quetiapine—Skin disorder—Cisplatin—esophageal cancer	0.000494	0.00169	CcSEcCtD
Quetiapine—Eye disorder—Capecitabine—esophageal cancer	0.000494	0.00169	CcSEcCtD
Quetiapine—Tinnitus—Capecitabine—esophageal cancer	0.000492	0.00169	CcSEcCtD
Quetiapine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000492	0.00168	CcSEcCtD
Quetiapine—Asthma—Methotrexate—esophageal cancer	0.000491	0.00168	CcSEcCtD
Quetiapine—Cardiac disorder—Capecitabine—esophageal cancer	0.00049	0.00168	CcSEcCtD
Quetiapine—ADRA2A—lymph node—esophageal cancer	0.000487	0.00481	CbGeAlD
Quetiapine—Eosinophilia—Methotrexate—esophageal cancer	0.000486	0.00166	CcSEcCtD
Quetiapine—Anorexia—Cisplatin—esophageal cancer	0.000485	0.00166	CcSEcCtD
Quetiapine—Pancreatitis—Methotrexate—esophageal cancer	0.000482	0.00165	CcSEcCtD
Quetiapine—Angiopathy—Capecitabine—esophageal cancer	0.000479	0.00164	CcSEcCtD
Quetiapine—Immune system disorder—Capecitabine—esophageal cancer	0.000477	0.00163	CcSEcCtD
Quetiapine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000476	0.00163	CcSEcCtD
Quetiapine—Hypotension—Cisplatin—esophageal cancer	0.000476	0.00163	CcSEcCtD
Quetiapine—ABCB1—digestive system—esophageal cancer	0.000475	0.00469	CbGeAlD
Quetiapine—Chills—Capecitabine—esophageal cancer	0.000474	0.00162	CcSEcCtD
Quetiapine—Abdominal discomfort—Methotrexate—esophageal cancer	0.000471	0.00161	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000464	0.00159	CcSEcCtD
Quetiapine—Mental disorder—Capecitabine—esophageal cancer	0.000463	0.00158	CcSEcCtD
Quetiapine—Malnutrition—Capecitabine—esophageal cancer	0.00046	0.00157	CcSEcCtD
Quetiapine—Dysuria—Methotrexate—esophageal cancer	0.000459	0.00157	CcSEcCtD
Quetiapine—Neutropenia—Methotrexate—esophageal cancer	0.000459	0.00157	CcSEcCtD
Quetiapine—Paraesthesia—Cisplatin—esophageal cancer	0.000457	0.00156	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000457	0.00156	CcSEcCtD
Quetiapine—Dyspnoea—Cisplatin—esophageal cancer	0.000454	0.00155	CcSEcCtD
Quetiapine—Flatulence—Capecitabine—esophageal cancer	0.000453	0.00155	CcSEcCtD
Quetiapine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000452	0.00155	CcSEcCtD
Quetiapine—Dysgeusia—Capecitabine—esophageal cancer	0.00045	0.00154	CcSEcCtD
Quetiapine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000448	0.00153	CcSEcCtD
Quetiapine—Back pain—Capecitabine—esophageal cancer	0.000445	0.00152	CcSEcCtD
Quetiapine—Decreased appetite—Cisplatin—esophageal cancer	0.000442	0.00151	CcSEcCtD
Quetiapine—Muscle spasms—Capecitabine—esophageal cancer	0.000442	0.00151	CcSEcCtD
Quetiapine—Pneumonia—Methotrexate—esophageal cancer	0.000441	0.00151	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000439	0.0015	CcSEcCtD
Quetiapine—Infestation NOS—Methotrexate—esophageal cancer	0.000438	0.0015	CcSEcCtD
Quetiapine—Infestation—Methotrexate—esophageal cancer	0.000438	0.0015	CcSEcCtD
Quetiapine—Depression—Methotrexate—esophageal cancer	0.000437	0.00149	CcSEcCtD
Quetiapine—Pain—Cisplatin—esophageal cancer	0.000435	0.00149	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000434	0.00149	CcSEcCtD
Quetiapine—Vision blurred—Capecitabine—esophageal cancer	0.000433	0.00148	CcSEcCtD
Quetiapine—Tremor—Capecitabine—esophageal cancer	0.000431	0.00147	CcSEcCtD
Quetiapine—Stomatitis—Methotrexate—esophageal cancer	0.000427	0.00146	CcSEcCtD
Quetiapine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000427	0.00146	CcSEcCtD
Quetiapine—Conjunctivitis—Methotrexate—esophageal cancer	0.000426	0.00146	CcSEcCtD
Quetiapine—Anaemia—Capecitabine—esophageal cancer	0.000425	0.00145	CcSEcCtD
Quetiapine—Sweating—Methotrexate—esophageal cancer	0.00042	0.00144	CcSEcCtD
Quetiapine—Feeling abnormal—Cisplatin—esophageal cancer	0.000419	0.00144	CcSEcCtD
Quetiapine—Malaise—Capecitabine—esophageal cancer	0.000415	0.00142	CcSEcCtD
Quetiapine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000414	0.00142	CcSEcCtD
Quetiapine—Epistaxis—Methotrexate—esophageal cancer	0.000413	0.00141	CcSEcCtD
Quetiapine—Vertigo—Capecitabine—esophageal cancer	0.000413	0.00141	CcSEcCtD
Quetiapine—Syncope—Capecitabine—esophageal cancer	0.000412	0.00141	CcSEcCtD
Quetiapine—Leukopenia—Capecitabine—esophageal cancer	0.000412	0.00141	CcSEcCtD
Quetiapine—Agranulocytosis—Methotrexate—esophageal cancer	0.000409	0.0014	CcSEcCtD
Quetiapine—Palpitations—Capecitabine—esophageal cancer	0.000406	0.00139	CcSEcCtD
Quetiapine—Loss of consciousness—Capecitabine—esophageal cancer	0.000404	0.00138	CcSEcCtD
Quetiapine—Body temperature increased—Cisplatin—esophageal cancer	0.000402	0.00138	CcSEcCtD
Quetiapine—Cough—Capecitabine—esophageal cancer	0.000401	0.00137	CcSEcCtD
Quetiapine—ABCB1—lung—esophageal cancer	0.000397	0.00392	CbGeAlD
Quetiapine—Hypertension—Capecitabine—esophageal cancer	0.000397	0.00136	CcSEcCtD
Quetiapine—Haemoglobin—Methotrexate—esophageal cancer	0.000395	0.00135	CcSEcCtD
Quetiapine—Hepatitis—Methotrexate—esophageal cancer	0.000393	0.00135	CcSEcCtD
Quetiapine—Haemorrhage—Methotrexate—esophageal cancer	0.000393	0.00135	CcSEcCtD
Quetiapine—Arthralgia—Capecitabine—esophageal cancer	0.000391	0.00134	CcSEcCtD
Quetiapine—Chest pain—Capecitabine—esophageal cancer	0.000391	0.00134	CcSEcCtD
Quetiapine—Myalgia—Capecitabine—esophageal cancer	0.000391	0.00134	CcSEcCtD
Quetiapine—Pharyngitis—Methotrexate—esophageal cancer	0.00039	0.00134	CcSEcCtD
Quetiapine—Anxiety—Capecitabine—esophageal cancer	0.00039	0.00133	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000389	0.00133	CcSEcCtD
Quetiapine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000388	0.00133	CcSEcCtD
Quetiapine—Discomfort—Capecitabine—esophageal cancer	0.000387	0.00132	CcSEcCtD
Quetiapine—Clozapine—CYP2A6—esophageal cancer	0.000386	0.14	CrCbGaD
Quetiapine—Urethral disorder—Methotrexate—esophageal cancer	0.000385	0.00132	CcSEcCtD
Quetiapine—Dry mouth—Capecitabine—esophageal cancer	0.000383	0.00131	CcSEcCtD
Quetiapine—Visual impairment—Methotrexate—esophageal cancer	0.000379	0.0013	CcSEcCtD
Quetiapine—Confusional state—Capecitabine—esophageal cancer	0.000378	0.00129	CcSEcCtD
Quetiapine—Hypersensitivity—Cisplatin—esophageal cancer	0.000375	0.00128	CcSEcCtD
Quetiapine—Infection—Capecitabine—esophageal cancer	0.000373	0.00128	CcSEcCtD
Quetiapine—Erythema multiforme—Methotrexate—esophageal cancer	0.000372	0.00127	CcSEcCtD
Quetiapine—Shock—Capecitabine—esophageal cancer	0.000369	0.00126	CcSEcCtD
Quetiapine—Nervous system disorder—Capecitabine—esophageal cancer	0.000368	0.00126	CcSEcCtD
Quetiapine—Eye disorder—Methotrexate—esophageal cancer	0.000367	0.00126	CcSEcCtD
Quetiapine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000367	0.00126	CcSEcCtD
Quetiapine—Tinnitus—Methotrexate—esophageal cancer	0.000367	0.00125	CcSEcCtD
Quetiapine—Tachycardia—Capecitabine—esophageal cancer	0.000366	0.00125	CcSEcCtD
Quetiapine—Asthenia—Cisplatin—esophageal cancer	0.000365	0.00125	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—esophageal cancer	0.000365	0.00125	CcSEcCtD
Quetiapine—Skin disorder—Capecitabine—esophageal cancer	0.000364	0.00125	CcSEcCtD
Quetiapine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000363	0.00124	CcSEcCtD
Quetiapine—Anorexia—Capecitabine—esophageal cancer	0.000358	0.00122	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—esophageal cancer	0.000357	0.00122	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—esophageal cancer	0.000355	0.00122	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000354	0.00121	CcSEcCtD
Quetiapine—Chills—Methotrexate—esophageal cancer	0.000353	0.00121	CcSEcCtD
Quetiapine—Hypotension—Capecitabine—esophageal cancer	0.000351	0.0012	CcSEcCtD
Quetiapine—Diarrhoea—Cisplatin—esophageal cancer	0.000348	0.00119	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—esophageal cancer	0.000344	0.00118	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—esophageal cancer	0.000342	0.00117	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000342	0.00117	CcSEcCtD
Quetiapine—Insomnia—Capecitabine—esophageal cancer	0.000339	0.00116	CcSEcCtD
Quetiapine—Paraesthesia—Capecitabine—esophageal cancer	0.000337	0.00115	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—esophageal cancer	0.000335	0.00115	CcSEcCtD
Quetiapine—Dyspnoea—Capecitabine—esophageal cancer	0.000335	0.00114	CcSEcCtD
Quetiapine—Back pain—Methotrexate—esophageal cancer	0.000331	0.00113	CcSEcCtD
Quetiapine—Dyspepsia—Capecitabine—esophageal cancer	0.00033	0.00113	CcSEcCtD
Quetiapine—Decreased appetite—Capecitabine—esophageal cancer	0.000326	0.00112	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000324	0.00111	CcSEcCtD
Quetiapine—Vomiting—Cisplatin—esophageal cancer	0.000324	0.00111	CcSEcCtD
Quetiapine—Fatigue—Capecitabine—esophageal cancer	0.000323	0.00111	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—esophageal cancer	0.000323	0.0011	CcSEcCtD
Quetiapine—Rash—Cisplatin—esophageal cancer	0.000321	0.0011	CcSEcCtD
Quetiapine—Constipation—Capecitabine—esophageal cancer	0.000321	0.0011	CcSEcCtD
Quetiapine—Pain—Capecitabine—esophageal cancer	0.000321	0.0011	CcSEcCtD
Quetiapine—Dermatitis—Cisplatin—esophageal cancer	0.000321	0.0011	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000318	0.00109	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—esophageal cancer	0.000316	0.00108	CcSEcCtD
Quetiapine—Feeling abnormal—Capecitabine—esophageal cancer	0.000309	0.00106	CcSEcCtD
Quetiapine—Malaise—Methotrexate—esophageal cancer	0.000309	0.00106	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—esophageal cancer	0.000307	0.00105	CcSEcCtD
Quetiapine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000307	0.00105	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—esophageal cancer	0.000306	0.00105	CcSEcCtD
Quetiapine—Nausea—Cisplatin—esophageal cancer	0.000302	0.00103	CcSEcCtD
Quetiapine—Cough—Methotrexate—esophageal cancer	0.000299	0.00102	CcSEcCtD
Quetiapine—Body temperature increased—Capecitabine—esophageal cancer	0.000297	0.00102	CcSEcCtD
Quetiapine—Abdominal pain—Capecitabine—esophageal cancer	0.000297	0.00102	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—esophageal cancer	0.000297	0.00101	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—esophageal cancer	0.000291	0.000997	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—esophageal cancer	0.000291	0.000997	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—esophageal cancer	0.000291	0.000997	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000289	0.00099	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—esophageal cancer	0.000288	0.000985	CcSEcCtD
Quetiapine—Nefazodone—ABCB1—esophageal cancer	0.000287	0.104	CrCbGaD
Quetiapine—Confusional state—Methotrexate—esophageal cancer	0.000282	0.000964	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000279	0.000956	CcSEcCtD
Quetiapine—Infection—Methotrexate—esophageal cancer	0.000277	0.00095	CcSEcCtD
Quetiapine—Hypersensitivity—Capecitabine—esophageal cancer	0.000276	0.000946	CcSEcCtD
Quetiapine—Olanzapine—ABCB1—esophageal cancer	0.000275	0.0997	CrCbGaD
Quetiapine—Nervous system disorder—Methotrexate—esophageal cancer	0.000274	0.000937	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000273	0.000936	CcSEcCtD
Quetiapine—ABCB1—lymph node—esophageal cancer	0.000272	0.00268	CbGeAlD
Quetiapine—Skin disorder—Methotrexate—esophageal cancer	0.000271	0.000929	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00027	0.000924	CcSEcCtD
Quetiapine—Asthenia—Capecitabine—esophageal cancer	0.000269	0.000921	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—esophageal cancer	0.000266	0.000911	CcSEcCtD
Quetiapine—Trazodone—ABCB1—esophageal cancer	0.000266	0.0964	CrCbGaD
Quetiapine—Pruritus—Capecitabine—esophageal cancer	0.000265	0.000909	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—esophageal cancer	0.000261	0.000893	CcSEcCtD
Quetiapine—Diarrhoea—Capecitabine—esophageal cancer	0.000257	0.000879	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000254	0.000871	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—esophageal cancer	0.000253	0.000865	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—esophageal cancer	0.000251	0.000858	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—esophageal cancer	0.000249	0.000852	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—esophageal cancer	0.000248	0.00085	CcSEcCtD
Quetiapine—Dizziness—Capecitabine—esophageal cancer	0.000248	0.000849	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—esophageal cancer	0.000246	0.000841	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—esophageal cancer	0.000243	0.000831	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000241	0.000825	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—esophageal cancer	0.000241	0.000824	CcSEcCtD
Quetiapine—Pain—Methotrexate—esophageal cancer	0.000239	0.000817	CcSEcCtD
Quetiapine—Vomiting—Capecitabine—esophageal cancer	0.000239	0.000816	CcSEcCtD
Quetiapine—Rash—Capecitabine—esophageal cancer	0.000237	0.00081	CcSEcCtD
Quetiapine—Dermatitis—Capecitabine—esophageal cancer	0.000236	0.000809	CcSEcCtD
Quetiapine—Headache—Capecitabine—esophageal cancer	0.000235	0.000804	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—esophageal cancer	0.00023	0.000788	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000228	0.000782	CcSEcCtD
Quetiapine—Nausea—Capecitabine—esophageal cancer	0.000223	0.000763	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—esophageal cancer	0.000221	0.000756	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—esophageal cancer	0.000221	0.000756	CcSEcCtD
Quetiapine—Fluphenazine—ABCB1—esophageal cancer	0.000215	0.078	CrCbGaD
Quetiapine—Hypersensitivity—Methotrexate—esophageal cancer	0.000206	0.000704	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—esophageal cancer	0.0002	0.000686	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—esophageal cancer	0.000198	0.000676	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—esophageal cancer	0.000191	0.000654	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—esophageal cancer	0.000185	0.000632	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—esophageal cancer	0.000178	0.000608	CcSEcCtD
Quetiapine—Rash—Methotrexate—esophageal cancer	0.000176	0.000603	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—esophageal cancer	0.000176	0.000602	CcSEcCtD
Quetiapine—Headache—Methotrexate—esophageal cancer	0.000175	0.000599	CcSEcCtD
Quetiapine—Trifluoperazine—ABCB1—esophageal cancer	0.000172	0.0624	CrCbGaD
Quetiapine—Nausea—Methotrexate—esophageal cancer	0.000166	0.000568	CcSEcCtD
Quetiapine—Clozapine—ABCB1—esophageal cancer	0.000144	0.0521	CrCbGaD
Quetiapine—DRD4—Signaling Pathways—EP300—esophageal cancer	1.14e-05	4.07e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CREBBP—esophageal cancer	1.13e-05	4.06e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	1.13e-05	4.04e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EP300—esophageal cancer	1.12e-05	4.02e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	1.12e-05	4.02e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	1.12e-05	4.01e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	1.12e-05	4.01e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	1.12e-05	4e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—EGFR—esophageal cancer	1.11e-05	3.99e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CREBBP—esophageal cancer	1.11e-05	3.99e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.11e-05	3.99e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CCND1—esophageal cancer	1.11e-05	3.98e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	1.11e-05	3.98e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	1.11e-05	3.97e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.11e-05	3.96e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.11e-05	3.96e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—esophageal cancer	1.1e-05	3.95e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	1.1e-05	3.95e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	1.1e-05	3.95e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CCND1—esophageal cancer	1.1e-05	3.93e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	1.1e-05	3.93e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	1.1e-05	3.93e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	1.1e-05	3.93e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	1.1e-05	3.93e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—EGFR—esophageal cancer	1.09e-05	3.92e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	1.09e-05	3.92e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	1.09e-05	3.91e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.09e-05	3.9e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.09e-05	3.9e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	1.09e-05	3.9e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—NOS3—esophageal cancer	1.09e-05	3.9e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—esophageal cancer	1.08e-05	3.88e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	1.08e-05	3.88e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	1.08e-05	3.86e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	1.08e-05	3.86e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	1.08e-05	3.85e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	1.07e-05	3.85e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EP300—esophageal cancer	1.07e-05	3.85e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	1.07e-05	3.82e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.07e-05	3.82e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CDKN1A—esophageal cancer	1.06e-05	3.8e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	1.06e-05	3.8e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	1.05e-05	3.76e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—EP300—esophageal cancer	1.05e-05	3.76e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.05e-05	3.76e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	1.05e-05	3.75e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.05e-05	3.75e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.04e-05	3.74e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	1.04e-05	3.72e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MYC—esophageal cancer	1.04e-05	3.71e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MYC—esophageal cancer	1.03e-05	3.71e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	1.03e-05	3.69e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.03e-05	3.69e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MYC—esophageal cancer	1.03e-05	3.68e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.03e-05	3.68e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EP300—esophageal cancer	1.02e-05	3.67e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—EP300—esophageal cancer	1.02e-05	3.65e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NOS3—esophageal cancer	1.02e-05	3.64e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	1.02e-05	3.64e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EGFR—esophageal cancer	1.01e-05	3.63e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EGFR—esophageal cancer	1.01e-05	3.63e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EP300—esophageal cancer	1.01e-05	3.62e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EP300—esophageal cancer	1.01e-05	3.62e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MYC—esophageal cancer	1.01e-05	3.61e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EGFR—esophageal cancer	1.01e-05	3.6e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NOS3—esophageal cancer	9.99e-06	3.58e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	9.98e-06	3.58e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NOS3—esophageal cancer	9.97e-06	3.57e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—NOS3—esophageal cancer	9.96e-06	3.57e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—esophageal cancer	9.94e-06	3.56e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	9.94e-06	3.56e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	9.91e-06	3.55e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MYC—esophageal cancer	9.9e-06	3.55e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	9.9e-06	3.55e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EGFR—esophageal cancer	9.84e-06	3.53e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	9.81e-06	3.52e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	9.78e-06	3.51e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MYC—esophageal cancer	9.77e-06	3.5e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.73e-06	3.49e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—esophageal cancer	9.69e-06	3.47e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	9.67e-06	3.47e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	9.58e-06	3.43e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCND1—esophageal cancer	9.56e-06	3.43e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—esophageal cancer	9.56e-06	3.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	9.54e-06	3.42e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	9.52e-06	3.41e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCND1—esophageal cancer	9.51e-06	3.41e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	9.5e-06	3.4e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	9.5e-06	3.4e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	9.47e-06	3.39e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	9.44e-06	3.38e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.4e-06	3.37e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MYC—esophageal cancer	9.36e-06	3.35e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	9.35e-06	3.35e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	9.35e-06	3.35e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ERBB2—esophageal cancer	9.33e-06	3.34e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	9.32e-06	3.34e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	9.3e-06	3.33e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	9.27e-06	3.32e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	9.25e-06	3.31e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	9.25e-06	3.31e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	9.2e-06	3.3e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	9.18e-06	3.29e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—esophageal cancer	9.15e-06	3.28e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	9.15e-06	3.28e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EP300—esophageal cancer	9.11e-06	3.27e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—esophageal cancer	9.11e-06	3.27e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	9.1e-06	3.26e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	9.09e-06	3.26e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—EP300—esophageal cancer	9.01e-06	3.23e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	8.95e-06	3.21e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MYC—esophageal cancer	8.92e-06	3.2e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.84e-06	3.17e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	8.81e-06	3.16e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EP300—esophageal cancer	8.8e-06	3.15e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MYC—esophageal cancer	8.8e-06	3.15e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MYC—esophageal cancer	8.8e-06	3.15e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—PIK3CA—esophageal cancer	8.79e-06	3.15e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—PIK3CA—esophageal cancer	8.78e-06	3.15e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EP300—esophageal cancer	8.75e-06	3.14e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	8.73e-06	3.13e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—esophageal cancer	8.72e-06	3.13e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	8.66e-06	3.1e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	8.61e-06	3.08e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—esophageal cancer	8.61e-06	3.08e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CREBBP—esophageal cancer	8.6e-06	3.08e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	8.54e-06	3.06e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EP300—esophageal cancer	8.51e-06	3.05e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—esophageal cancer	8.51e-06	3.05e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	8.5e-06	3.05e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—esophageal cancer	8.5e-06	3.04e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—esophageal cancer	8.44e-06	3.03e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—PIK3CA—esophageal cancer	8.41e-06	3.01e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CREBBP—esophageal cancer	8.4e-06	3.01e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCND1—esophageal cancer	8.39e-06	3.01e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EP300—esophageal cancer	8.38e-06	3e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	8.29e-06	2.97e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—EP300—esophageal cancer	8.27e-06	2.96e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—esophageal cancer	8.27e-06	2.96e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCND1—esophageal cancer	8.26e-06	2.96e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCND1—esophageal cancer	8.24e-06	2.95e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	8.21e-06	2.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	8.19e-06	2.93e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—esophageal cancer	8.13e-06	2.91e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	8.12e-06	2.91e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	8.11e-06	2.91e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	8.09e-06	2.9e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.07e-06	2.89e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—esophageal cancer	8.02e-06	2.88e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	7.99e-06	2.86e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	7.97e-06	2.86e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	7.95e-06	2.85e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	7.94e-06	2.85e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MYC—esophageal cancer	7.94e-06	2.85e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	7.92e-06	2.84e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.91e-06	2.84e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	7.84e-06	2.81e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	7.82e-06	2.8e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	7.77e-06	2.78e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	7.76e-06	2.78e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.74e-06	2.77e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EP300—esophageal cancer	7.73e-06	2.77e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—NOS3—esophageal cancer	7.7e-06	2.76e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—esophageal cancer	7.68e-06	2.75e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—esophageal cancer	7.67e-06	2.75e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—esophageal cancer	7.63e-06	2.73e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EP300—esophageal cancer	7.6e-06	2.72e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EP300—esophageal cancer	7.59e-06	2.72e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—EP300—esophageal cancer	7.58e-06	2.72e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	7.57e-06	2.71e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EP300—esophageal cancer	7.56e-06	2.71e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EP300—esophageal cancer	7.54e-06	2.7e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—esophageal cancer	7.53e-06	2.7e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—NOS3—esophageal cancer	7.52e-06	2.69e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	7.51e-06	2.69e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—esophageal cancer	7.5e-06	2.69e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	7.47e-06	2.68e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	7.47e-06	2.68e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EP300—esophageal cancer	7.46e-06	2.67e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—esophageal cancer	7.46e-06	2.67e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EP300—esophageal cancer	7.44e-06	2.67e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—esophageal cancer	7.42e-06	2.66e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—esophageal cancer	7.32e-06	2.62e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—esophageal cancer	7.3e-06	2.62e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	7.27e-06	2.6e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	7.26e-06	2.6e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—esophageal cancer	7.22e-06	2.59e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—esophageal cancer	7.22e-06	2.59e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	7.14e-06	2.56e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—NOS3—esophageal cancer	7.08e-06	2.54e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—esophageal cancer	7.05e-06	2.52e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	6.92e-06	2.48e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—esophageal cancer	6.88e-06	2.46e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	6.74e-06	2.42e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—esophageal cancer	6.73e-06	2.41e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—esophageal cancer	6.67e-06	2.39e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—esophageal cancer	6.62e-06	2.37e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—esophageal cancer	6.61e-06	2.37e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—esophageal cancer	6.59e-06	2.36e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—esophageal cancer	6.58e-06	2.36e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—esophageal cancer	6.57e-06	2.35e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—esophageal cancer	6.52e-06	2.34e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	6.51e-06	2.33e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—esophageal cancer	6.5e-06	2.33e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—esophageal cancer	6.49e-06	2.32e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.48e-06	2.32e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—esophageal cancer	6.48e-06	2.32e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	6.48e-06	2.32e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—esophageal cancer	6.46e-06	2.32e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	6.44e-06	2.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	6.42e-06	2.3e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	6.36e-06	2.28e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	6.34e-06	2.27e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	6.3e-06	2.26e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—esophageal cancer	6.3e-06	2.26e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—esophageal cancer	6.26e-06	2.24e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	6.2e-06	2.22e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	6.12e-06	2.19e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—esophageal cancer	6.09e-06	2.18e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	6.03e-06	2.16e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—esophageal cancer	6e-06	2.15e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	5.89e-06	2.11e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—EP300—esophageal cancer	5.86e-06	2.1e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—EP300—esophageal cancer	5.72e-06	2.05e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	5.71e-06	2.05e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	5.62e-06	2.01e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	5.61e-06	2.01e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	5.61e-06	2.01e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	5.59e-06	2e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	5.58e-06	2e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—esophageal cancer	5.53e-06	1.98e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	5.52e-06	1.98e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	5.51e-06	1.97e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—esophageal cancer	5.44e-06	1.95e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—esophageal cancer	5.43e-06	1.95e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—esophageal cancer	5.41e-06	1.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—esophageal cancer	5.39e-06	1.93e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—EP300—esophageal cancer	5.39e-06	1.93e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—esophageal cancer	5.34e-06	1.91e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—esophageal cancer	5.33e-06	1.91e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.17e-06	1.85e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	5.12e-06	1.83e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	4.95e-06	1.77e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NOS3—esophageal cancer	4.63e-06	1.66e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.33e-06	1.55e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.24e-06	1.52e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.23e-06	1.52e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.99e-06	1.43e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—EP300—esophageal cancer	3.52e-06	1.26e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.61e-06	9.34e-06	CbGpPWpGaD
